Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Is Cancer a Metabolic Disorder?

Effects of Social and Economic Deprivation on Cancer Mortality

Investigating the Molecular Mechanisms of Cancer

Hot vs Cold: the differences between tumor types

Acidosis and Tumor Progression

Living with Cancer Pain

What is Tumorigenesis?

What is Cancer?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer History

See more featured articles »

Cancer Screening Considerations: Balancing the Benefits and Risks

Insight into Cancer Vaccines

What is Merkel Cell Carcinoma?

Hypoxia Markers and Their Importance

The Cancer Cell Surface Proteome as a Therapeutic Target

Cancer Prognosis

Cancer Research

The Biochemistry of Breast Cancer Screening

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Targeted Cancer Therapies

Secondary Brain Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

What Causes Cancer?

What Role do Biobanks Play in Cancer Research?

Cancer Pathophysiology

Secondary Lung Cancer

Cutaneous Manifestations of Internal Malignancy

Myc Mutations and Cancer

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Cancer Diagnosis

Exploiting Enzymes in Cancer Diagnosis and Therapy

Assay for Monitoring and Treating Malignant Brain Tumors

Pediatric Cancer

Cancer Prevention: Lowering your Risk

Insights into Oncofertility

Caring for a Loved One with Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Transforming Cancer Care through Genomic Testing

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Management

Cancer Epidemiology

What is the Tumor Microenvironment?

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

CDK9 and Cancer

British Pioneers in Cancer Biology

Why are Cancer Cell Lines Useful?

Cancer Pain

Cancer Pain Management

Using Biomarkers to Detect Cancer

Cancer Glossary

Cancer Symptoms

Overview of Cell Viability and Cytotoxicity

Cancer Classification

What is Immunochemotherapy?

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Metastatic Migration in Cancer may be Influenced by Metabolism

The Effects of Cancer on Family Life

What is Cancer of Unknown Primary?

TARDIS: The Improved Method of Detecting Breast Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

Latest Cancer News and Research

Common chemical exposures in pregnancy may be linked to early attention and memory

Researchers examined whether prenatal exposure to aromatic amines and cotinine was associated with attention, processing speed, and memory in 250 infants assessed at 7.5 months. The study found mixed patterns across cognitive measures, with several estimates suggesting poorer attention or memory but carrying substantial statistical uncertainty.

23 Sep 2026

Cancer-related DNA changes may appear in blood years before diagnosis

Researchers found that genome-wide plasma cfDNA methylation profiles collected before diagnosis contained early molecular signatures associated with future prostate and breast cancer, with prostate silencer methylation providing the stronger risk stratification. Breast enhancer signals were weaker and varied by subtype and disease stage, indicating that cfDNA methylation may have greater value for risk assessment and surveillance than as a standalone diagnostic test.

23 Sep 2026

Blood test detects more cancers when added to standard screening

A single blood draw that screens for more than 50 cancers substantially increased cancer detection when added to standard screening, identifying cancers that otherwise might have gone undetected until later stages, according to a new study from the Oregon Health & Science University Knight Cancer Institute.

22 Sep 2026

Higher ultra-processed food intake linked to multiple health risks

A higher ultra processed food (UPF) intake is linked to a heightened risk of several major chronic health issues, such as digestive diseases, high blood pressure, and metabolic syndrome/diabetes, as well as death, finds a pooled data analysis of the available evidence, published in the open access journal Family Medicine and Community Health.

22 Sep 2026

Cancer incidence rises faster among people with type 2 diabetes

A nationwide study being presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) has found that people with type 2 diabetes (T2D) have a higher risk of developing cancer, with cancer incidence rising more among people with T2D than those without diabetes over the past 25 years, largely driven by obesity-related cancers.

22 Sep 2026

Study identifies potential resistance mechanism in metastatic uveal melanoma

Uveal melanoma is a rare and aggressive cancer that starts inside the eye and often spreads to the liver. Few treatment options exist, and unlike some forms of skin melanoma which can respond well to modern therapies, metastatic uveal melanoma (MUM) remains difficult to treat.

22 Sep 2026

Simple prompts may improve cancer screening compliance among high-risk groups

People getting recommended screening tests for one cancer can be reminded about other relevant screenings. It's a simple way to increase compliance for potentially life-saving tests.

22 Sep 2026

Loneliness and social isolation cost people years of healthy life

The numbers paint a grim picture. Roughly half of all U.S. adults are lonely, according to a 2023 report, and nearly as many feel socially isolated.

22 Sep 2026

New scanning method detects basal cell carcinoma early using AI

Researchers at FAU combine optical diagnosis method with AI-assisted image recognition.

22 Sep 2026

Low spinal bone density may predict faster brain aging

Researchers at Johns Hopkins University found that lower bone mineral density in the spine was associated with faster cognitive decline and accelerated age-related white matter injury, according to a new study published today in Radiology, a journal of the Radiological Society of North America.

22 Sep 2026

Binghamton University scientists win seed funding for medical technologies

Two Binghamton University faculty members will receive seed funding through the State University of New York (SUNY) Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists.

22 Sep 2026

Study identifies B cells as drivers of immunotherapy-related colitis

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which are adaptive immune cells, in triggering and sustaining colitis occurring as a side effect of immune checkpoint inhibitors, a widely used form of cancer immunotherapy.

22 Sep 2026

Marine carbohydrates offer valuable new resources for drug development

The ocean contains diverse carbohydrates that could serve as valuable resources for drug development. Algae, marine animals and microorganisms produce polysaccharides and related molecules with structures that are uncommon on land, including distinctive sulfate patterns, sugar linkages and branched architectures.

22 Sep 2026

KAIST researchers develop NUDGE technology to steer cell fate

Which genes need to be controlled to guide a stem cell toward a desired cell type, or to modulate an immune cell's inflammatory response? A Korean research team has developed a general-purpose computational framework that identifies the key targets needed to steer a cell toward a desired state with a single temporary intervention, without permanently altering its genes.

22 Sep 2026

New spin-out launches technology to revolutionize hormone disorder diagnosis

The University of Birmingham and Imperial College London have announced the launch of Intelligent Mass Spec Solutions Ltd (IMS Solutions), a new spin-out that is set to revolutionize diagnosis of conditions featuring disordered steroid hormone metabolism.

22 Sep 2026

Garvan research reveals hidden inflammation behind high colon cancer risk

New research from the Garvan Institute of Medical Research has revealed for the first time that two closely related bowel diseases, currently treated in the same way, are fundamentally different.

22 Sep 2026

City of Hope develops adaptive plug-and-play CAR T technology to attack tumors

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have developed a new "plug-and-play" technology that adds engineered molecules to chimeric antigen receptor (CAR) T cells after treatment, allowing scientists to better control the cells and redirect them to attack different types of cancer.

22 Sep 2026

Simple test could take the pain out of womb cancer check

A new test to identify cells collected from urine and vaginal fluid could help rule out womb and other cancers in most women who experience bleeding after the menopause, find University of Manchester researchers.

22 Sep 2026

Regular exercisers show distinct metabolic and immune signatures in blood

Researchers compared blood samples from 40 regular exercisers and 46 sedentary adults and found differences in metabolites, blood chemistry, and immune cell gene activity. The patterns suggested greater fatty acid use and altered immune signaling among exercisers, but the study could not establish that exercise caused these differences.

21 Sep 2026

Chronic DNA damage response may contribute to biological aging

A new review was published in Volume 18 of Aging on August 31, 2026, titled "The guardian paradox: DNA damage response overactivation as an integrative driver of aging – a tumor suppressor–negative regulator framework."

21 Sep 2026